期刊文献+

联合检测EB病毒不同抗体及EB病毒DNA在鼻咽癌血清学诊断中的价值 被引量:47

Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma
原文传递
导出
摘要 目的 同时检测EB病毒(EBV) Rta-IgG、衣壳抗原(VCA)-IgA、早期抗原(EA)-IgA、EBV-DNA,评价EBV血清学联合检测在鼻咽癌诊断中的价值.方法 收集2012年1-12月中山大学肿瘤防治中心经病理确诊的131例治疗前鼻咽癌、52例非鼻咽癌的相似症状患者和148名健康体检者的血清和血浆,应用免疫酶染色法检测血清VCA-IgA、EA-IgA抗体;ELISA法检测Rta-IgG抗体;用实时荧光定量PCR分析血浆EBV-DNA.比较单独应用和联合应用各指标在鼻咽癌血清学诊断中的敏感度和特异度.结果 鼻咽癌组Rta-IgG、VCA-IgA、EA-IgA、EBV-DNA阳性率均高于鼻咽相关疾病组及健康对照组(均P<0.01).Rta-IgG、EBV-DNA阳性率及EBV-DNA水平随鼻咽癌临床分期增高而增高(均P <0.05);VCA-IgA、EA-IgA阳性率与鼻咽癌临床分期无关(P>0.05).Rta-IgG和EBV-DNA的受试者工作特征曲线下面积分别为0.901和0.827,4个指标对鼻咽癌血清学诊断效能均较好,单项检测的敏感度和特异度分别为:Rta-IgG:77.9% 、92.5%,VCA-IgA:93.1%、91.5%,EA-IgA:74.8%、99.5%,EBV-DNA:64.9%、97.0%;联合检测的敏感度和特异度分别为97.7%、83.5%.结论 联合检测Rta-IgG、VCA-IgA、EA-IgA、EBV-DNA可提高EBV血清学在鼻咽癌诊断中的效益. Objective To evaluate the values of combined detection method of EB viral Rta-IgG,VCA-IgA,EA-IgA and EB viral DNA in the diagnosis of nasopharyngeal carcinoma (NPC).Methods Serum and plasma samples from 131 untreated NPC patients,52 non-NPC patients with NPC-like symptoms and 148 healthy donors from January to December 2012 were collected.Immunoenzymatic staining was used to detect VCA-IgA and EA-IgA in sera.ELISA was performed to detect Rta-IgG antibody in sera and realtime fluorescent quantitative PCR for measuring EBV DNA in plasma.The clinical characteristics of 3 groups were compared.ROC curve and correlation analyses were performed to assess the detection assays for the diagnosis of NPC.Results The positive rates of EBV Rta-IgG,VCA-IgA,EA-IgA and EBV DNA in untreated NPC patient group were higher than those in other two groups.The differences were statistically significant (all P <0.01).The differences of Rta-IgG antibody positive rates,EBV-DNA levels and EBV-DNA positive rates at different clinical stages were statistically significant (all P < 0.05).The positive rates of VCA-IgA and EA-IgA were not related with clinical stages (P > 0.05).Areas under ROC curve for RtaIgG and EBV-DNA were 0.901 and 0.827 respectively.All four diagnostic assays demonstrated excellent efficiency.The sensitivity and specificity of individual assays were as follows:Rta-IgG:77.9%,92.5% ;VCA-IgA 93.1%,91.5% ; EA-IgA:74.8%,99.5% ; EBV-DNA 64.9%,97.0%.The sensitivity and specificity of combined assays were 97.7% and 83.5% respectively.Conclusion Combined detection method of EB viral Rta-IgG,VCA-IgA,EA-IgA and EB viral DNA are efficient for the diagnosis of NPC.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第44期3516-3519,共4页 National Medical Journal of China
关键词 疱疹病毒4型 鼻咽肿瘤 血清学试验 DNA 病毒 Herpesvirus 4,human Nasopharyngeal neoplasms Serologic tests DNA, viral
  • 相关文献

参考文献9

  • 1Wille CK, Nawandar DM, Panfil AR, et al. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol,2013 ,87 :935-950.
  • 2Cheng WM, Chan KH, Chen HL, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer, 2002,97:489 -492.
  • 3Mutirangura A, Pomthanakasem W, Theamhoonlers A, et al. Epstein-Ban" viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res,1998, 4:665-669.
  • 4Feng P, Cban SH, Soo MY, et al. Antibody response to Epstein- Barr virus Rta protein in patients with nasopharyngeal carcinoma:a new serologic parameter for diagnosis. Cancer, 2001, 92: 1872-1880.
  • 5任军,周玲,曾毅.BRLF1-EBV的一种立即早期基因的研究进展[J].中国肿瘤,2005,14(6):372-375. 被引量:2
  • 6张昌卿,宗永生,黄宝珍,孙韵,叶永照,冯凯涛,李经略,张锋.提高EB病毒血清学在诊断鼻咽癌中的效益[J].中华肿瘤杂志,2002,24(4):356-359. 被引量:25
  • 7郑裕明,蔡永林,成积儒,李军,莫永坤,高健全,董智荣,钟青燕.鼻咽癌EB病毒Rta/IgG抗体检测的诊断价值[J].中华实验和临床病毒学杂志,2009,23(4):285-287. 被引量:11
  • 8Sener AG, Afsar I, Pinar E. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state. J Virol Methods, 2009,159:300-302.
  • 9张玉,郜红艺,冯惠霞,邓玲,黄马燕,胡斌,程钢,吴秋良,崔念基,邵建永.鼻咽癌病人血浆和外周血白细胞EB病毒DNA定量分析[J].中华医学杂志,2004,84(12):982-986. 被引量:16

二级参考文献42

  • 1宗永生,杨传民.用原位杂交技术探讨EB病毒在鼻咽癌发生中的作用[J].中华病理学杂志,1993,22(6):330-332. 被引量:13
  • 2任军,周玲,曾毅.EBV立即早期基因-BRLF1和BZLF1的研究进展[J].国外医学(病毒学分册),2005,12(4):125-128. 被引量:1
  • 3任军,张晓梅,张晓光,李红霞,周玲,曾毅.以Rtac2/3为抗原用于鼻咽癌病人检测的初步研究[J].中华微生物学和免疫学杂志,2006,26(11):1057-1059. 被引量:31
  • 4Armitage RJ, Rowe DJ, Beverly PC. A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B ceils. EurJ Immunol, 1988, 18: 67.
  • 5Lee MA, Diamond ME, Yates JL. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol, 1999, 73: 2974.
  • 6Feng P, Ren EC, Liu D, et al. Expression of Epstein-Barr virus lyric gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J Gen Viral, 2000, 81: 2417-2423.
  • 7Feng P, Chan SH, Rachel Soo MY, et al. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharngeal carcinoma. Cancer, 2001, 92: 1872-1880.
  • 8Cheng WM, Chan KH, Chert HL, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer, 2002, 97: 489-492.
  • 9Kraus R, PeiTigoue J, Mertz J. ZEB negatively regulates the lyric-switch BZLF1 gene promoter of Epstein-Barr virus[J]. J Virol,2003,77:199-207.
  • 10Liu PF,Speck SH. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta[J]. Virology,2003,310:199-206.

共引文献48

同被引文献351

引证文献47

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部